ENDORFICA

Serial Number 87486031
606

Registration Progress

Application Filed
Jun 13, 2017
Under Examination
Oct 24, 2017
Approved for Publication
Aug 29, 2017
Published for Opposition
Aug 29, 2017
Registered

Trademark Image

ENDORFICA

Basic Information

Serial Number
87486031
Filing Date
June 13, 2017
Published for Opposition
August 29, 2017
Abandonment Date
November 30, 2020
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Nov 30, 2020
Classes
005

Rights Holder

Alkermes Pharma Ireland Limited

03
Address
CONNAUGHT HOUSE
1 BURLINGTON ROAD
DUBLIN
IE

Ownership History

Alkermes Pharma Ireland Limited

Original Applicant
03
DUBLIN IE

Alkermes Pharma Ireland Limited

Owner at Publication
03
DUBLIN IE

Legal Representation

Attorney
Norm J. Rich

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

31 events
Date Code Type Description Documents
Nov 30, 2020 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Nov 30, 2020 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Apr 28, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 25, 2020 EX5G S SOU EXTENSION 5 GRANTED Loading...
Apr 25, 2020 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Apr 17, 2020 EXT5 S SOU EXTENSION 5 FILED Loading...
Apr 17, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 15, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 11, 2019 EX4G S SOU EXTENSION 4 GRANTED Loading...
Oct 11, 2019 EXT4 S SOU EXTENSION 4 FILED Loading...
Oct 11, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 1, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 27, 2019 EX3G S SOU EXTENSION 3 GRANTED Loading...
Feb 27, 2019 EXT3 S SOU EXTENSION 3 FILED Loading...
Feb 27, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 12, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Sep 10, 2018 EX2G S SOU EXTENSION 2 GRANTED Loading...
Sep 10, 2018 EXT2 S SOU EXTENSION 2 FILED Loading...
Sep 10, 2018 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 31, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 29, 2018 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jan 29, 2018 EXT1 S SOU EXTENSION 1 FILED Loading...
Jan 29, 2018 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 24, 2017 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Aug 29, 2017 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Aug 29, 2017 PUBO A PUBLISHED FOR OPPOSITION Loading...
Aug 9, 2017 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jul 21, 2017 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jul 21, 2017 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 19, 2017 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jun 16, 2017 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of diseases mediated by an opioid receptor, namely, major depressive disorder, chronic depression, severe unipolar recurrent major depressive episodes, dysthymic disorder, depressive neurosis and neurotic depression, melancholic depression, atypical depression, reactive depression, treatment resistant depression, seasonal affective disorder and pediatric depression, premenstrual syndrome, premenstrual dysphoric disorder, hot flashes, bipolar disorders or manic depression, bipolar I disorder, bipolar II disorder and cyclothymic disorder, anxiety, post traumatic stress disorder, obsessive compulsive disorder and borderline personality disorder

Classification

International Classes
005